Financhill
Back

Anavex Life Sciences Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
58

AVXL
Anavex Life Sciences

Last Price:
7.30
Seasonality Move:
-9.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Anavex Life Sciences Price Quote

$7.30
+0.01 (+6.8%)
(Updated: November 5, 2024 at 5:14 AM ET)

Anavex Life Sciences Key Stats

Buy
58
Anavex Life Sciences (AVXL) is a Buy

Day range:
$6.62 - $7.44
52-week range:
$3.25 - $10.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.76%

Volume:
2M
Avg. volume:
790.7K
1-year change:
20.7%
Market cap:
$618.2M
Revenue:
$0
EPS:
$-0.51

How Much Does Anavex Life Sciences Make?

Data Unavailable

Is Anavex Life Sciences Growing As A Company?

Data Unavailable

Anavex Life Sciences Stock Price Performance

What Is Anavex Life Sciences 52-Week High & Low?

Anavex Life Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Anavex Life Sciences?

Is Anavex Life Sciences Cash Flow Positive?

  • What Is AVXL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$30M
  • What Is Anavex Life Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $13.9M
  • What Is Anavex Life Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Anavex Life Sciences Return On Invested Capital

Data Unavailable

Anavex Life Sciences Earnings Date & Stock Price

Anavex Life Sciences Competitors

Anavex Life Sciences Dividend Yield

Anavex Life Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 22.22%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 35.47
Upside from Last Price: 386.59%

Major Shareholders

  • How many AVXL shares are owned by institutional investors?
    41.9M AVXL shares are owned by institutional investors
  • How many AVXL shares are owned by insiders?
    4.1M AVXL shares are owned by insiders